Overall rank by patents
#2,131
of 49,997 tracked assignees
USPTO PatentsView assignee record - 185 granted patents across 31 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Ossur ranks #2,131 of 49,997 tracked US assignees by granted-patent volume, with 185 patents across 31 technology areas.
USPTO PatentsView assignee plate
Corpus R2131 · Foreign Corporation #2,131 · 185 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Canon Anelva Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Aisan Kogyo · near
55 score
Basf Mobile… · near
55 score
Chang Chun Petrochem… · near
55 score
Hesai Technology · near
55 score
Ossur Iceland EHF · this assignee
55 score
3D Lighting… · lowest
7 score
What this shows Ossur's Innovation Score is 54.5/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Ossur Iceland EHF is a focused PatentsView assignee: 31 CPC subclasses with 84.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (30 grants) versus a trough of 1 in 2016. By volume, Ossur sits between Canon Anelva Corporation and Raytheon BBN Technologies Corp..
From 2019–2021 to 2022–2024, Ossur Iceland EHF moved from 67 to 85 grants (1.27x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #683. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Canon Anelva Corporation
185 patents
Cooler Master Co., Ltd.
185 patents
Fujitsu Semiconductor Limited
185 patents
National Taiwan University of Science and Technology
185 patents
PETRÓLEO Brasileiro S.A.—PETROBRAS
185 patents
Proterial, Ltd.
185 patents
PerkinElmer Health Sciences, Inc.
185 patents
Raytheon BBN Technologies Corp.
185 patents
Ossur Iceland EHF
185 patents
What this shows Ossur holds 185 patents at rank #2,131, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,131 in granted patent volume.
Other assignees with the most granted patents in Ossur's primary technology class.
Two PlainPatent-derived peer sets for Ossur, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (55 here).
Nearest assignees by average claims per patent (13.9 here).
Ossur's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
55 Top 8% higher than 92% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 0.5% |
| 2017 | 8 | 4.3% |
| 2018 | 10 | 5.4% |
| 2019 | 27 | 14.6% |
| 2020 | 20 | 10.8% |
| 2021 | 20 | 10.8% |
| 2022 | 30 | 16.2% |
| 2023 | 27 | 14.6% |
| 2024 | 28 | 15.1% |
| 2025partial year | 14 | 7.6% |
Top 15 of 31 technology areas
Overall rank by patents
#2,131
of 49,997 tracked assignees
54.5 out of 100
What to do with this data
Ossur Iceland EHF's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.